Zobrazeno 1 - 10
of 47
pro vyhledávání: '"S. V. Fedosenko"'
Autor:
Yu. O. Rodionova, E. A. Starovoitova, S. V. Fedosenko, S. V. Nesterovich, A. I. Ivanova, M. B. Arzhanik, O. L. Semenova, A. P. Zima, D. A. Vinokurova, O. A. Denisova
Publikováno v:
Архивъ внутренней медицины, Vol 14, Iss 2, Pp 132-143 (2024)
Despite significant progress in the field of prevention, early diagnosis and antibacterial therapy, community-acquired pneumonia still retains the status of not only the most common among acute infectious diseases, but is also a frequent source of se
Externí odkaz:
https://doaj.org/article/ca5a757696f44845becf484eb4aff7c4
Autor:
A. M. Gubareva, S. V. Fedosenko, D. A. Vinokurova, S. V. Nesterovich, E. S. Kulikov, D. V. Polyakova, E. A. Starovoitova
Publikováno v:
Архивъ внутренней медицины, Vol 14, Iss 1, Pp 15-22 (2024)
This article describes two clinical observations of the use of mepolizumab in patients with severe uncontrolled asthma with a mixed granulocytic pattern of inflammation in the bronchi and comorbid pathology. The mixed granulocytic form of severe asth
Externí odkaz:
https://doaj.org/article/01c8b42c71374f938de13ce9efc294c5
Autor:
S. Yu. Dobner, S. V. Fedosenko, A. Yu. Dobrodeev, N. D. Yarovoy, E. N. Samtsov, А. V. Dubakov, E. A. Starovoitova, О. A. Denisova, N. A. Kirillova
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 5, Pp 49-59 (2023)
The purpose of the study was to compare the efficacy of regular prolonged inhalation therapy with tiotropium bromide delivered via the Respimat inhaler and short-acting bronchodilator (SAB) therapy with ipratropium bromide/fenoterol in the perioperat
Externí odkaz:
https://doaj.org/article/c104d8e309f949e1a49491430e531617
Autor:
E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 3, Pp 298-306 (2023)
Cardiovascular disease is the most common cause of death worldwide. In this regard, there is a need to find and implement effective methods for the prevention and treatment of such diseases. Lifestyle modification is an important component of a compl
Externí odkaz:
https://doaj.org/article/c8fabf6b5a2844d1abcd7683078f0959
Autor:
S. Yu. Dobner, S. V. Fedosenko, E. O. Rodionov, N. D. Yarovoy, V. A. Petrov, S. A. Tuzikov, E. A. Starovoitova, I. A. Samykina
Publikováno v:
Бюллетень сибирской медицины, Vol 21, Iss 3, Pp 41-49 (2022)
Background. A combination of different types of lung cancer and chronic obstructive pulmonary disease (COPD) is very common. COPD, accompanied by ventilation disorders and, often, respiratory failure, is a significant additional risk factor for morta
Externí odkaz:
https://doaj.org/article/1f3a332189644842ab1064efd4bdd895
Autor:
M. M. Fedotova, V. M. Malchuk, V. A. Churilin, A. A. Zapevalova, D. O. Yakovleva, D. D. Olenius, A. M. Kamenshchikova, S. V. Fedosenko, O. S. Fedorova
Publikováno v:
Антибиотики и Химиотерапия, Vol 67, Iss 1-2, Pp 45-52 (2022)
Background. The growth of antibiotic resistance is an urgent problem of modern medicine associated with the irrational use of antibacterial drugs. The solution to this problem requires a comprehensive analysis of the situation not only from the patie
Externí odkaz:
https://doaj.org/article/3350cc10f8fc4e01ae5ff4da45c5ddaf
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 1, Pp 59-66 (2020)
Objective. To estimate the value of measuring plasma eosinophilic cationic protein (ECP) levels in patients with chronic obstructive pulmonary disease (COPD) as a potential biomarker for determining the activity of eosinophilic inflammation. To compa
Externí odkaz:
https://doaj.org/article/fa3d5ebadfe74c61be5577c5e1d1cdcd
Autor:
S. V. Fedosenko, M. A. Karnaushkina, L. M. Ogorodova, V. A. Petrov, I. A. Deev, E. S. Kulikov, A. E. Sazonov
Publikováno v:
Бюллетень сибирской медицины, Vol 15, Iss 5, Pp 159-165 (2017)
The purpose of this study is to evaluate the ability of systemic glucocorticosteroids administered during the exacerbation of the disease to have a modifying effect on the qualitative and quantitative composition of the oropharyngeal microbiota.Mater
Externí odkaz:
https://doaj.org/article/5704221ddc5b41c5973314261bd6cbad
Autor:
O. I. Zvonareva, E. S. Kulikov, I. A. Deev, O. S. Kobyakova, O. S. Fedorova, N. A. Kirillova, E. A. Starovoytova, N. G. Zhukova, I. A. Zhukova, V. V. Esip, E. D. Schastnyy, N. V. Khurkhurova, L. Yu. Nikitina, T. S. Golosova, I. D. Pimenov, M. A. Netaeva, S. V. Fedosenko
Publikováno v:
Бюллетень сибирской медицины, Vol 15, Iss 4, Pp 40-51 (2016)
Introduction. Currently, clinical trials (CT) remain the only technology, which provides proof of efficacy and safety of new drugs and their subsequent release to the market. Medical researcher and informed consent (IC) are the main (and often the on
Externí odkaz:
https://doaj.org/article/460c20e96e9a4c0aa94d31a4c3c9eb6a
Autor:
M. A. Karnaushkina, S. V. Fedosenko, A. E. Sazonov, V. A. Petrov, R. M. Vakoluyk, L. I. Dvoretckiy, L. M. Ogorodova
Publikováno v:
Архивъ внутренней медицины, Vol 6, Iss 4, Pp 14-20 (2016)
In recent years, medical community has come to the conclusion that the currently used prognostic criteria of the course of COPD, do not allow to predict the further development of the disease, its complications and outcomes with high accuracy. The mo
Externí odkaz:
https://doaj.org/article/65c62c10a5d4441d89044f6752692015